Agree on the timing of the corporate update. It should be released while the stock had some momentum. Besides the uplist blunder, I was hoping for more details in the Phase 3 PR. Maybe they will be discussed in the update.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
